Bioinformatics Center

User Tools

Site Tools

You are here: home » home » publications
home:publications

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision 		Previous revision
Next revision Both sides next revision
home:publications [16.11.2019 19:14]
Teemu Kuulasmaa [2018] 		home:publications [19.11.2019 10:46]
Juha Kekäläinen
Line 5: Line 5:
  
 ### 2019 ### 2019
 +
 +Karttunen, J.; Heiskanen, M.; Lipponen, A.; Poulsen, D.; Pitkänen, A. **Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies**, Int. J. Mol. Sci. 2019, 20(6), 1259; https://doi.org/10.3390/ijms20061259
  
 Failli M, Paananen J, Fortino V. **Prioritizing target-disease associations with novel safety and efficacy scoring methods**, //Sci Rep// 2019, https://doi.org/10.1038/s41598-019-46293-7 Failli M, Paananen J, Fortino V. **Prioritizing target-disease associations with novel safety and efficacy scoring methods**, //Sci Rep// 2019, https://doi.org/10.1038/s41598-019-46293-7
Line 10: Line 12:
 Timonen O, Särkkä M, Fülöp T, Mattsson A, Kekäläinen J, Paananen J, **Varanto: variant enrichment analysis and annotation**, Bioinformatics 2019, https://doi.org/10.1093/bioinformatics/btz046 Timonen O, Särkkä M, Fülöp T, Mattsson A, Kekäläinen J, Paananen J, **Varanto: variant enrichment analysis and annotation**, Bioinformatics 2019, https://doi.org/10.1093/bioinformatics/btz046
  
-Lipponen A, Natunen T, Hujo M, Ciszek R, Hämäläinen E, Tohka J, Hiltunen M, Paananen J, Poulsen D, Kansanen E, Ndode-Ekane X, Levonen A-L, Pitkänen A, **In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury—Lessons Learned**, //Int. J. Mol. Sci.// 2019, https://doi.org/10.3390/ijms20215395+Lipponen A, Natunen T, Hujo M, Ciszek R, Hämäläinen E, Tohka J, Hiltunen M, Paananen J, Poulsen D, Kansanen E, Ndode-Ekane XE, Levonen AL, Pitkänen A, **In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury—Lessons Learned**, //Int. J. Mol. Sci.// 2019, https://doi.org/10.3390/ijms20215395
  
-Pölönen P, Mehtonen J, Lin J, Liuksiala T, Häyrynen S, Teppo S, Mäkinen A, Kumar A, Malani D, Pohjolainen V, Porkka K, Heckman C, May P, Hautamäki V, Granberg K, Lohi O, Nykter M, Heinäniemi M: **Hemap: An interactive online resource for characterizing molecular phenotypes across hematologic malignancies**, //Cancer Research// 2019, https://doi.org/10.1158/0008-5472.CAN-18-2970+Pölönen P, Mehtonen J, Lin J, Liuksiala T, Häyrynen S, Teppo S, Mäkinen A, Kumar A, Malani D, Pohjolainen V, Porkka K, Heckman CA, May P, Hautamäki V, Granberg K, Lohi O, Nykter M, Heinäniemi M: **Hemap: An interactive online resource for characterizing molecular phenotypes across hematologic malignancies**, //Cancer Research// 2019, https://doi.org/10.1158/0008-5472.CAN-18-2970
  
 Mehtonen J, Pölönen P, Häyrynen S, Lin J, Liuksiala T, Granberg K, Lohi O, Hautamäki V, Nykter M, Heinäniemi M. **Data-driven characterization of molecular phenotypes across heterogenous sample collections**, Mehtonen J, Pölönen P, Häyrynen S, Lin J, Liuksiala T, Granberg K, Lohi O, Hautamäki V, Nykter M, Heinäniemi M. **Data-driven characterization of molecular phenotypes across heterogenous sample collections**,
Line 24: Line 26:
  
 Niskanen H, Tuszynska I, Zaborowski R, Heinäniemi M, Ylä-Herttuala S, Wilczynski B, Kaikkonen MU.**Endothelial cell differentiation is encompassed by changes in long range interactions between inactive chromatin regions** //Nucleic Acids Res.// 2018, 10.1093/nar/gkx1214. Niskanen H, Tuszynska I, Zaborowski R, Heinäniemi M, Ylä-Herttuala S, Wilczynski B, Kaikkonen MU.**Endothelial cell differentiation is encompassed by changes in long range interactions between inactive chromatin regions** //Nucleic Acids Res.// 2018, 10.1093/nar/gkx1214.
-- Lewis, JD, Evans, AC, Tohka J. **T1 white/gray contrast as a predictor of chronological age, and an index of cognitive performance** //NeuroImage// 2018, https://doi.org/10.1016/j.neuroimage.2018.02.050 + 
-- Marttinen M, Paananen J, Neme A, Mitra V, Takalo M, Natunen T,+Lewis, JD, Evans, AC, Tohka J. **T1 white/gray contrast as a predictor of chronological age, and an index of cognitive performance** //NeuroImage// 2018, https://doi.org/10.1016/j.neuroimage.2018.02.050 
 + 
 +Marttinen M, Paananen J, Neme A, Mitra V, Takalo M, Natunen T,
 Paldanius KMA, Mäkinen P, Bremang M, Kurki MI, Rauramaa T, Leinonen V, Paldanius KMA, Mäkinen P, Bremang M, Kurki MI, Rauramaa T, Leinonen V,
 Soininen H, Haapasalo A, Pike I, Hiltunen M **A multiomic approach to characterize the temporal sequence in Alzheimer's disease-related pathology**, //Neurobiol Dis.// 2019, https://doi.org/10.1016/j.nbd.2018.12.009 Soininen H, Haapasalo A, Pike I, Hiltunen M **A multiomic approach to characterize the temporal sequence in Alzheimer's disease-related pathology**, //Neurobiol Dis.// 2019, https://doi.org/10.1016/j.nbd.2018.12.009
-- Martiskainen H, Takalo M, Solomon A, Stančáková A, Marttinen M,+ 
 +Martiskainen H, Takalo M, Solomon A, Stančáková A, Marttinen M,
 Natunen T, Haapasalo A, Herukka SK, Kuusisto J, Soininen H, Kivipelto Natunen T, Haapasalo A, Herukka SK, Kuusisto J, Soininen H, Kivipelto
 M, Laakso M, Hiltunen M. **Decreased plasma C-reactive protein levels in APOE ε4 allele carriers**, //Ann Clin Transl Neurol.// 2018. https://doi.org/10.1002/acn3.639. M, Laakso M, Hiltunen M. **Decreased plasma C-reactive protein levels in APOE ε4 allele carriers**, //Ann Clin Transl Neurol.// 2018. https://doi.org/10.1002/acn3.639.
-- Kaartokallio T, Utge S, Klemetti MM, Paananen J, Pulkki K, Romppanen+ 
 +Kaartokallio T, Utge S, Klemetti MM, Paananen J, Pulkki K, Romppanen
 J, Tikkanen I, Heinonen S, Kajantie E, Kere J, Kivinen K, Pouta A, J, Tikkanen I, Heinonen S, Kajantie E, Kere J, Kivinen K, Pouta A,
 Lakkisto P, Laivuori H. **Fetal Microsatellite in the Heme Oxygenase 1 Promoter Is Associated With Severe and Early-Onset Preeclampsia** , //Hypertension// 2018, https://doi.org/10.1161/HYPERTENSIONAHA.117.10425. Lakkisto P, Laivuori H. **Fetal Microsatellite in the Heme Oxygenase 1 Promoter Is Associated With Severe and Early-Onset Preeclampsia** , //Hypertension// 2018, https://doi.org/10.1161/HYPERTENSIONAHA.117.10425.
Line 37: Line 43:
 ### 2017 or earlier ### 2017 or earlier
  
-- to be listed here later...+Paananen, J. **Bioinformatics in the Identification of Novel Targets and Pathways in Neurodegenerative Diseases**, Curr Genet Med Rep (2017) 5:15–21, https://doi.org/10.1007/s40142-017-0115-8
home/publications.txt · Last modified: 15.01.2024 13:53 by Administrator

Page Tools